A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation

Oncotarget

Volumn 6, Issue 5, 2015, Pages 3375-3393

  Ruggiero, Carmen ^a,c   Fragassi, Giorgia ^a   Grossi, Mauro ^a   Picciani, Benedetta ^a   Di Martino, Rosaria ^b   Capitani, Mirco ^a   Buccione, Roberto ^a   Luini, Alberto ^b   Sallese, Michele ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^c INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Cancer cell invasion; Cell signalling; Src family kinases

Indexed keywords

CORTACTIN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITIDE; PROTEIN ASAP1; PROTEIN KDELR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ASAP1 PROTEIN, HUMAN; CTTN PROTEIN, HUMAN; KDELR1 PROTEIN, HUMAN; KDELR2 PROTEIN, HUMAN; RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; BINDING AFFINITY; CELL MEMBRANE; CELL SIZE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; EXTRACELLULAR MATRIX; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GOLGI COMPLEX; HUMAN; HUMAN CELL; INVADOPIA; KDELR1 GENE; KDELR2 GENE; MELANOMA; MELANOMA CELL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; CELL MOTION; ENZYME ACTIVATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; PODOSOME; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL LINE, TUMOR; CELL MOVEMENT; CORTACTIN; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GOLGI APPARATUS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS; PHOSPHORYLATION; PODOSOMES; RECEPTORS, PEPTIDE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION; VESICULAR TRANSPORT PROTEINS;

EID: 84923268864     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3270     Document Type: Article

References (62)

1. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature. 1999; 402:C47- 52.
2. Csete ME, Doyle JC. Reverse engineering of biological complexity. Science. 2002; 295:1664-1669.
3. Sontag ED. Molecular systems biology and control. Eur J Control. 2005; 11:396-435.
4. Cancino J, Capalbo A, Di Campli A, Giannotta M, Rizzo R, Jung JE, Di Martino R, Persico M, Heinklein P, Sallese M, Luini A. Control Systems of Membrane Transport at the Interface between the Endoplasmic Reticulum and the Golgi. Dev Cell. 2014; 30:280-294.
5. Giannotta M, Ruggiero C, Grossi M, Cancino J, Capitani M, Pulvirenti T, Consoli GM, Geraci C, Fanelli F, Luini A, Sallese M. The KDEL receptor couples to Galphaq/11 to activate Src kinases and regulate transport through the Golgi. EMBO J. 2012; 31:2869-2881.
6. Pulvirenti T, Giannotta M, Capestrano M, Capitani M, Pisanu A, Polishchuk RS, San Pietro E, Beznoussenko GV, Mironov AA, Turacchio G, et al. A traffic-activated Golgibased signalling circuit coordinates the secretory pathway. Nat Cell Biol. 2008; 10:912-922.
7. Saudek V. Cystinosin, MPDU1, SWEETs and KDELR belong to a well-defined protein family with putative function of cargo receptors involved in vesicle trafficking. PLoS One. 2012; 7:e30876.
8. Yee DC, Shlykov MA, Vastermark A, Reddy VS, Arora S, Sun EI, Saier MH, Jr. The transporter-opsin-G proteincoupled receptor (TOG) superfamily. FEBS J. 2013; 280:5780-5800.
9. Zhai Y, Heijne WH, Smith DW, Saier MH, Jr. Homologues of archaeal rhodopsins in plants, animals and fungi: structural and functional predications for a putative fungal chaperone protein. Biochim Biophys Acta. 2001; 1511:206- 223.
10. Lewis MJ, Pelham HR. A human homologue of the yeast HDEL receptor. Nature. 1990; 348:162-163.
11. Munro S, Pelham HR. A C-terminal signal prevents secretion of luminal ER proteins. Cell. 1987; 48:899-907.
12. Pelham HR. Evidence that luminal ER proteins are sorted from secreted proteins in a post-ER compartment. EMBO J. 1988; 7:913-918.
13. Semenza JC, Hardwick KG, Dean N, Pelham HR. ERD2, a yeast gene required for the receptor-mediated retrieval of luminal ER proteins from the secretory pathway. Cell. 1990; 61:1349-1357.
14. Klumperman J. Transport between ER and Golgi. Curr Opin Cell Biol. 2000; 12:445-449.
15. Martinez-Menarguez JA, Geuze HJ, Slot JW, Klumperman J. Vesicular tubular clusters between the ER and Golgi mediate concentration of soluble secretory proteins by exclusion from COPI-coated vesicles. Cell. 1999; 98:81-90.
16. Wieland FT, Gleason ML, Serafini TA, Rothman JE. The rate of bulk flow from the endoplasmic reticulum to the cell surface. Cell. 1987; 50:289-300.
17. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol. 1997; 13:513-609.
18. Yeatman TJ. A renaissance for SRC. Nat Rev Cancer. 2004; 4:470-480.
19. Caldieri G, Buccione R. Aiming for invadopodia: organizing polarized delivery at sites of invasion. Trends Cell Biol. 2010; 20:64-70.
20. Nakahara H, Mueller SC, Nomizu M, Yamada Y, Yeh Y, Chen WT. Activation of beta1 integrin signaling stimulates tyrosine phosphorylation of p190RhoGAP and membraneprotrusive activities at invadopodia. J Biol Chem. 1998; 273:9-12.
21. Mueller SC, Ghersi G, Akiyama SK, Sang QX, Howard L, Pineiro-Sanchez M, Nakahara H, Yeh Y, Chen WT. A novel protease-docking function of integrin at invadopodia. J Biol Chem. 1999; 274:24947-24952.
22. Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 2005; 168:441- 452.
23. Kimura F, Iwaya K, Kawaguchi T, Kaise H, Yamada K, Mukai K, Matsubara O, Ikeda N, Kohno N. Epidermal growth factor-dependent enhancement of invasiveness of squamous cell carcinoma of the breast. Cancer Sci. 2010; 101:1133-1140.
24. Tague SE, Muralidharan V, D'Souza-Schorey C. ADPribosylation factor 6 regulates tumor cell invasion through the activation of the MEK/ERK signaling pathway. Proc Natl Acad Sci U S A. 2004; 101:9671-9676.
25. Pignatelli J, Tumbarello DA, Schmidt RP, Turner CE. Hic-5 promotes invadopodia formation and invasion during TGFbeta- induced epithelial-mesenchymal transition. J Cell Biol. 2012; 197:421-437.
26. Eckert MA, Lwin TM, Chang AT, Kim J, Danis E, Ohno- Machado L, Yang J. Twist1-induced invadopodia formation promotes tumor metastasis. Cancer Cell. 2011; 19:372-386.
27. Lucas JT, Jr., Salimath BP, Slomiany MG, Rosenzweig SA. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene. 2010; 29:4449-4459.
28. Chen WT, Chen JM, Parsons SJ, Parsons JT. Local degradation of fibronectin at sites of expression of the transforming gene product pp60src. Nature. 1985; 316:156- 158.
29. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006; 66:3034-3043.
30. Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res. 2006; 312:1240-1253.
31. Onodera Y, Hashimoto S, Hashimoto A, Morishige M, Mazaki Y, Yamada A, Ogawa E, Adachi M, Sakurai T, Manabe T, et al. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. EMBO J. 2005; 24:963-973.
32. Bharti S, Inoue H, Bharti K, Hirsch DS, Nie Z, Yoon HY, Artym V, Yamada KM, Mueller SC, Barr VA, Randazzo PA. Src-dependent phosphorylation of ASAP1 regulates podosomes. Mol Cell Biol. 2007; 27:8271-8283.
33. Kirkbride KC, Sung BH, Sinha S, Weaver AM. Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adh Migr. 2011; 5:187-198.
34. Weaver AM. Cortactin in tumor invasiveness. Cancer Lett. 2008; 265:157-166.
35. Seals DF, Azucena EF, Jr., Pass I, Tesfay L, Gordon R, Woodrow M, Resau JH, Courtneidge SA. The adaptor protein Tks5/Fish is required for podosome formation and function, and for the protease-driven invasion of cancer cells. Cancer Cell. 2005; 7:155-165.
36. Zhang LH, Tian B, Diao LR, Xiong YY, Tian SF, Zhang BH, Li WM, Ren H, Li Y, Ji JF. Dominant expression of 85-kDa form of cortactin in colorectal cancer. J Cancer Res Clin Oncol. 2006; 132:113-120.
37. Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene. 1999; 18:4440-4449.
38. Coopman PJ, Do MT, Thompson EW, Mueller SC. Phagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacity. Clin Cancer Res. 1998; 4:507-515.
39. Condeelis J, Segall JE. Intravital imaging of cell movement in tumours. Nat Rev Cancer. 2003; 3:921-930.
40. Yamaguchi H, Wyckoff J, Condeelis J. Cell migration in tumors. Curr Opin Cell Biol. 2005; 17:559-564.
41. Bowden ET, Coopman PJ, Mueller SC. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 2001; 63:613-627.
42. Baldassarre M, Pompeo A, Beznoussenko G, Castaldi C, Cortellino S, McNiven MA, Luini A, Buccione R. Dynamin participates in focal extracellular matrix degradation by invasive cells. MolBiolCell. 2003; 14:1074-1084.
43. Ayala I, Babia T, Baldassarre M, Pompeo A, Fabra A, Kok JW, Luini A, Buccione R, Egea G. Morphological and biochemical analysis of the secretory pathway in melanoma cells with distinct metastatic potential. FEBS Lett. 1999; 451:315-320.
44. Raykhel I, Alanen H, Salo K, Jurvansuu J, Nguyen VD, Latva-Ranta M, Ruddock L. A molecular specificity code for the three mammalian KDEL receptors. J Cell Biol. 2007; 179:1193-1204.
45. Capitani M, Sallese M. The KDEL receptor: new functions for an old protein. FEBS Lett. 2009; 583:3863-3871.
46. Tehrani S, Tomasevic N, Weed S, Sakowicz R, Cooper JA. Src phosphorylation of cortactin enhances actin assembly. Proc Natl Acad Sci U S A. 2007; 104:11933-11938.
47. Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tete S, Luini A, Buccione R. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J Cell Sci. 2008; 121:369- 378.
48. Brown MT, Andrade J, Radhakrishna H, Donaldson JG, Cooper JA, Randazzo PA. ASAP1, a phospholipiddependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol Cell Biol. 1998; 18:7038-7051.
49. Randazzo PA, Hirsch DS. Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling. Cell Signal. 2004; 16:401-413.
50. Ehlers JP, Worley L, Onken MD, Harbour JW. DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res. 2005; 11:3609-3613.
51. Lin D, Watahiki A, Bayani J, Zhang F, Liu L, Ling V, Sadar MD, English J, Fazli L, So A, et al. ASAP1, a gene at 8q24, is associated with prostate cancer metastasis. Cancer Res. 2008; 68:4352-4359.
52. Paz H, Pathak N, Yang J. Invading one step at a time: the role of invadopodia in tumor metastasis. Oncogene. 2014; 33:4193-4202.
53. Taipale J, Keski-Oja J. Growth factors in the extracellular matrix. FASEB J. 1997; 11:51-59.
54. Dean N, Pelham HR. Recycling of proteins from the Golgi compartment to the ER in yeast. JCell Biol. 1990; 111:369- 377.
55. Pelham HR. Evidence that luminal ER proteins are sorted from secreted proteins in a post-ER compartment. EMBO J. 1988; 7:913-918.
56. Yamamoto K, Hamada H, Shinkai H, Kohno Y, Koseki H, Aoe T. The KDEL receptor modulates the endoplasmic reticulum stress response through mitogen-activated protein kinase signaling cascades. JBiolChem. 2003; 278:34525- 34532.
57. Peters LR, Raghavan M. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells. J Immunol. 2011; 187:919- 931.
58. Lewis MJ, Pelham HR. Ligand-induced redistribution of a human KDEL receptor from the Golgi complex to the endoplasmic reticulum. Cell. 1992; 68:353-364.
59. Mueller SC, Chen WT. Cellular invasion into matrix beads: localization of beta 1 integrins and fibronectin to the invadopodia. J Cell Sci. 1991; 99 ( Pt 2):213-225.
60. Ayala I, Giacchetti G, Caldieri G, Attanasio F, Mariggio S, Tete S, Polishchuk R, Castronovo V, Buccione R. Faciogenital dysplasia protein Fgd1 regulates invadopodia biogenesis and extracellular matrix degradation and is upregulated in prostate and breast cancer. Cancer Res. 2009; 69:747-752.
61. Baldassarre M, Ayala I, Beznoussenko G, Giacchetti G, Machesky LM, Luini A, Buccione R. Actin dynamics at sites of extracellular matrix degradation. Eur J Cell Biol. 2006; 85:1217-1231.
62. Bader GD, Donaldson I, Wolting C, Ouellette BF, Pawson T, Hogue CW. BIND--The Biomolecular Interaction Network Database. Nucleic Acids Res. 2001; 29:242-245.